Mirae Asset Global Etfs Holdings Ltd. Allakos Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Allakos Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 34,167 shares of ALLK stock, worth $46,808. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,167Holding current value
$46,808% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALLK
# of Institutions
93Shares Held
71MCall Options Held
43.8KPut Options Held
1.4K-
Bvf Inc San Francisco, CA16.6MShares$22.7 Million0.51% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$8.42 Million0.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT5MShares$6.85 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$4.81 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.42MShares$4.69 Million0.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $116M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...